Results 11 to 20 of about 10,532 (169)

Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection. [PDF]

open access: yesToxins (Basel), 2022
Voiding dysfunction is a common but bothersome problem in both men and women. Urethral sphincter botulinum toxin A (BoNT-A) injections could serve as an option in refractory cases. This study analyzed the efficacy and outcome predictors of the injections
Kao YL, Ou YC, Tsai KJ, Kuo HC.
europepmc   +2 more sources

Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection? [PDF]

open access: yesToxins (Basel), 2023
Spinal cord injuries (SCI) have a profound impact on autonomic systems, sometimes resulting in multi-organ dysfunction, including of the neurogenic bladder.
Chow PM, Kuo HC.
europepmc   +2 more sources

Prediction of Postradical Prostatectomy Urinary Incontinence Through the Combination of the Urethral Pressure Profile With Electromyography of the Urethral Sphincter. [PDF]

open access: yesInt Neurourol J, 2022
Purpose We tested the hypothesis that the urethral pressure profile, in combination with electromyography of the urethral sphincter, may be useful as a predictor of urinary incontinence after radical prostatectomy (RP).
Talavera JR   +4 more
europepmc   +2 more sources

Therapeutic Efficacy and Mid-Term Durability of Urethral Sphincter Platelet-Rich Plasma Injections to Treat Postprostatectomy Stress Urinary Incontinence. [PDF]

open access: yesBiomedicines, 2022
Platelet-rich plasma (PRP) is used for tissue repair and regeneration. Herein, we investigated the therapeutic efficacy and mid-term durability of injections of PRP into the urethral sphincter for the management of postprostatectomy incontinence (PPI ...
Lee PJ, Jiang YH, Kuo HC.
europepmc   +2 more sources

Impact of Urethral Sphincter Electrophysiology on Botulinum Toxin A Treatment in Women with Non-Neurogenic Dysfunctional Voiding. [PDF]

open access: yesBiomedicines
Dysfunctional voiding (DV) is an abnormal urethral sphincter activity during voiding in neurologically normal individuals. Urethral sphincter botulinum toxin A (BoNT-A) injection has been used to treat DV, but the results have not been completely ...
Chang TL, Jiang YH, Kuo HC.
europepmc   +2 more sources

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction. [PDF]

open access: yesToxins (Basel), 2022
Purpose: This study aimed to investigate improvement in voiding condition after the initial botulinum toxin A (BoNT-A) injection into the urethral sphincter among patients with chronic spinal cord injury (SCI) and voiding dysfunction.
Lee CL, Jhang JF, Jiang YH, Kuo HC.
europepmc   +2 more sources

Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia. [PDF]

open access: yesJ Rehabil Med, 2022
Objective: To investigate the effects of concomitant injections of botulinum toxin-A (BoNT-A) into the detrusor and external urethral sphincter muscles in suprasacral spinal cord injured patients with detrusor overactivity and detrusor sphincter ...
Huang YH, Chen SL.
europepmc   +2 more sources

Clinical and Functional Anatomy of the Urethral Sphincter [PDF]

open access: diamondInternational Neurourology Journal, 2012
Continence and micturition involve urethral closure. Especially, insufficient strength of the pelvic floor muscles including the urethral sphincter muscles causes urinary incontinence (UI).
Junyang Jung   +2 more
doaj   +3 more sources

A novel management for postprostatectomy urinary incontinence: platelet-rich plasma urethral sphincter injection. [PDF]

open access: yesSci Rep, 2021
Platelet-rich plasma (PRP) is the most innovative blood-derived product used in regenerative medicine. We aimed to investigate the therapeutic efficacy of PRP urethral sphincter injection for the management of postprostatectomy incontinence (PPI).
Lee PJ, Jiang YH, Kuo HC.
europepmc   +2 more sources

The Efficacy and Mid-term Durability of Urethral Sphincter Injections of Platelet-Rich Plasma in Treatment of Female Stress Urinary Incontinence. [PDF]

open access: yesFront Pharmacol, 2022
Aims: This study investigated the therapeutic effect of repeated urethral sphincter injections of autologous platelet-rich plasma (PRP) in treatment of stress urinary incontinence (SUI) in women due to intrinsic sphincter deficiency (ISD) refractory to ...
Chiang CH, Kuo HC.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy